| scholarly article | Q13442814 |
| P2093 | author name string | J L Montastruc | |
| A Herxheimer | |||
| H Bagheri | |||
| G Roche | |||
| C Rossard | |||
| F Montastruc | |||
| L Cantaloube | |||
| L Pochard | |||
| M Abou Taam | |||
| N Bouscaren | |||
| P2860 | cites work | Benfluorex and unexplained valvular heart disease: a case-control study | Q21091138 |
| Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus | Q28295644 | ||
| Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data | Q31111908 | ||
| Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet | Q35567642 | ||
| Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review | Q35928690 | ||
| Pharmacovigilance | Q36081511 | ||
| How patients' experiences contribute to decision making: illustrations from DIPEx (personal experiences of health and illness). | Q43731847 | ||
| Database of patients' experiences (DIPEx): a multi-media approach to sharing experiences and information. | Q52078964 | ||
| Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France | Q57419199 | ||
| P433 | issue | 1 | |
| P921 | main subject | social media | Q202833 |
| P304 | page(s) | 53-55 | |
| P577 | publication date | 2013-10-21 | |
| P1433 | published in | Journal of Clinical Pharmacy and Therapeutics | Q15753553 |
| P1476 | title | Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France. | |
| P478 | volume | 39 |
| Q26824283 | Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review |
| Q42015192 | Assessment of Web-Based Consumer Reviews as a Resource for Drug Performance. |
| Q55109854 | Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions. |
| Q57294636 | Detection of Cases of Noncompliance to Drug Treatment in Patient Forum Posts: Topic Model Approach (Preprint) |
| Q51416225 | Detection of Cases of Noncompliance to Drug Treatment in Patient Forum Posts: Topic Model Approach. |
| Q37716829 | Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts |
| Q40955862 | Filtering Entities to Optimize Identification of Adverse Drug Reaction From Social Media: How Can the Number of Words Between Entities in the Messages Help? |
| Q28543522 | Interactions between medical residents and drug companies: a national survey after the Mediator® affair |
| Q26752684 | Patient Participation and the Use of Ehealth Tools for Pharmacoviligance |
| Q38410148 | Social Media Listening for Routine Post-Marketing Safety Surveillance |
| Q31007428 | Symptom clusters in women with breast cancer: an analysis of data from social media and a research study |
| Q27687556 | Systematic review on the prevalence, frequency and comparative value of adverse events data in social media. |
| Q42672233 | Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database |
| Q55285491 | Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology. |
Search more.